Trusted Press Release Distribution   Plans | Login    

Briefing Search


Author Details
Future Market Insights

Bookmark and Share
Prognostic Biomarkers Market Poised for Steady Growth in the Future
Prognostic Biomarkers Market: Global Industry Analysis and Opportunity Assessment 2017-2027, 2/11/2019 - Prognostic Biomarkers are the type of biomarkers that track the progression of a disease with or without treatment. They assess the aggressiveness of the disease and calculate the risk of recurrence or median survival for particular type of malignancy. According to an article published in Journal of Clinical and Cellular Immunology, the field of biomarkers has expanded dramatically in the last 5-6 years with the advancement in high throughput technologies such as mass spectroscopy, genomic and proteomic arrays, sequencing, and many more. Intensifying research in this field can be seen from the increase in the number of publications for novel prognostic biomarkers especially in the field of cancer. A new research presented at Association for the Study of Diabetes (EASD) 2016 Annual Meeting suggests the combination of prognostic biomarkers which could be helpful in noninvasive screening for pancreatic carcinoma in patients with new-onset diabetes. According to an article published in Ebiomedicine, recently researchers have identified 788 potential biomarkers in blood that could be used to develop an early stage carcinoma screening test for the general population.

Novel drug efficiency in clinical trials on a certain population is determined using prognostic biomarkers. Hence, prognostic biomarkers have remarkable potential to affect the success rate of clinical trials. They also help in assessing the need and strategy of treatment for specific patients. In the era of personalized medicines and advanced cancer therapeutics, prognostic markers provide the precise selection of treatment for a patient. Thus, helps in reducing the side effects of chemotherapeutic drugs. For the further prediction and development of novel prognostic biomarkers, collaboration of statistical and bioinformatics data is also required.

Prognostic Biomarkers Market: Key Players

Some of the key players in the prognostic biomarkers industry include Roche diagnostics, Qiagen, Johnson and Johnson, GE Healthcare, Siemens Healthcare, Merck & Co. Inc. and many others.

Request Sample Report@ [URL][/URL]

FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2019 Proserve Technology, Inc.